Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 3 | LIF | 87.5 | 72 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | LIF | 107.0 | 51 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | LIF | 96.0 | 59 | ||||
N2586 | 3 | LIF | 129.5 | 62 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | LIF | 158.0 | 79 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | LIF | 113.0 | 63 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | LIF | 351.0 | 56 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | LIF | 196.5 | 62 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | LIF | 109.0 | 79 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | LIF | 123.0 | 65 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | LIF | 115.0 | 54 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 91.0 | 74 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 97.0 | 60 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 80.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 75.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 77.5 | 68 | |
N2586 | IL-17A | 100 | ng/mL | 3 | LIF | 147.0 | 61 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 136.0 | 67 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 127.5 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 330.0 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 119.0 | 50 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | LIF | 115.5 | 52 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | LIF | 84.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 90.0 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | LIF | 77.0 | 49 |